[go: up one dir, main page]

AR126835A1 - DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE - Google Patents

DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE

Info

Publication number
AR126835A1
AR126835A1 ARP220102245A ARP220102245A AR126835A1 AR 126835 A1 AR126835 A1 AR 126835A1 AR P220102245 A ARP220102245 A AR P220102245A AR P220102245 A ARP220102245 A AR P220102245A AR 126835 A1 AR126835 A1 AR 126835A1
Authority
AR
Argentina
Prior art keywords
dimethoxyphenethylamine
bromo
derivatives
deuterated analogs
stereoisomer
Prior art date
Application number
ARP220102245A
Other languages
Spanish (es)
Inventor
Matthew Alexander James Duncton
Sam Clark
Original Assignee
Terran Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terran Biosciences Inc filed Critical Terran Biosciences Inc
Publication of AR126835A1 publication Critical patent/AR126835A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En el presente documento, se proporcionan análogos deuterados de 4-bromo-2,5-dimetoxifenetilamina (2C-B) y compuestos relacionados y sus usos para el tratamiento de afecciones relacionadas con una enfermedad neurológica. Reivindicación 1: Un compuesto de la fórmula (1), o un estereoisómero o una sal farmacéuticamente aceptable de este, donde R es H, D, F, Cl, Br, I, Me, Et, ⁿPr, ⁱPr, ᶜPr, ⁿBu, Ph, CH₂Ph, C& Reivindicación 117: Un método para aumentar la plasticidad neuronal en un sujeto que lo necesita, que comprende administrar al sujeto una cantidad eficaz del compuesto o estereoisómero o una sal farmacéuticamente aceptable según una cualquiera de las reivindicaciones 1 a 111, o la composición farmacéutica según la reivindicación 112.Provided herein are deuterated analogues of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and related compounds and their uses for the treatment of conditions related to neurological disease. Claim 1: A compound of formula (1), or a stereoisomer or pharmaceutically acceptable salt thereof, where R is H, D, F, Cl, Br, I, Me, Et, ⁿPr, ⁱPr, ᶜPr, ⁿBu, Ph, CH₂Ph, C& Claim 117: A method of increasing neuronal plasticity in a subject in need thereof, comprising administering to the subject an effective amount of the compound or stereoisomer or a pharmaceutically acceptable salt according to any one of claims 1 to 111, or the pharmaceutical composition according to claim 112.

ARP220102245A 2020-02-23 2022-08-19 DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE AR126835A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063313216P 2020-02-23 2020-02-23
US202063275394P 2020-11-03 2020-11-03
US202163235541P 2021-08-20 2021-08-20

Publications (1)

Publication Number Publication Date
AR126835A1 true AR126835A1 (en) 2023-11-22

Family

ID=89061611

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102245A AR126835A1 (en) 2020-02-23 2022-08-19 DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE

Country Status (1)

Country Link
AR (1) AR126835A1 (en)

Similar Documents

Publication Publication Date Title
CL2021002965A1 (en) Antiviral compounds containing nitrile.
EA202092169A1 (en) USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-CoV-2 INFECTION
AR128931A1 (en) COMPLEMENT B FACTOR INHIBITORS AND USES THEREOF
CL2023000881A1 (en) Compounds and their use in cancer treatment
AR127247A1 (en) CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS
DOP2024000146A (en) PARP7 INHIBITORS
AR127470A1 (en) LRRK2 INHIBITORS
CL2021002575A1 (en) Pyrrole compounds
CO2025003099A2 (en) Compounds for cancer treatment
AR127497A1 (en) PYRDAZIN-3(2H)-ONE DERIVATIVES
CL2023000418A1 (en) Heteroaryl-substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
CU20200102A7 (en) COMPOUNDS DERIVED FROM ISOINDOLIN-1,2,4-TRIAZOL-3-CARBONITRILE USEFUL FOR THE TREATMENT OF KINETOPLASTID DISEASES
RU2007138582A (en) ORAL DOSAGE FORMS OF HEMCITABINE DERIVATIVES
AR127496A1 (en) CD73 COMPOUNDS
AR126835A1 (en) DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE
DOP2025000090A (en) Cancer treatment methods using isoquinoline or 6-azaquinoline derivatives
AR128100A1 (en) COMPOUNDS FOR THE TREATMENT OF HAIR LOSS
AR033779A1 (en) USEFUL COMPOUNDS IN REFLUX DISEASE
AR130303A1 (en) PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
UY39466A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS
CR20240216A (en) NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER
AR133135A1 (en) COMPOUNDS THAT MODULATE KRAS
AR127582A1 (en) METHODS FOR THE TREATMENT OF CANCER
AR130467A1 (en) PHENALKYLAMINES AND METHODS FOR MANUFACTURING AND USING THE SAME
AR132037A1 (en) PYRIDAZINYL AMINO DERIVATIVES AS ALK5 RECEPTOR INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure